Internal Medicine, Cardiovascular Disease · Florence, SC
NPI
1548227804
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
101 William H. Johnson Street, Suite 600
Florence, SC, 29506
Phone (843) 667-1891
Groups this clinician bills Medicare through
Medicare paid, 2024
$426K
9,800 services
Medicare patients, 2024
3,882
Average age 76
Drug cost, 2024
$2.2M
9,449 prescriptions
Company payments, 2025
$1,312
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gavin M Leask was code 93010 (electrocardiogram), 2,389 times for 1,801 patients. In total Gavin M Leask billed 9,800 services in 53 codes, and Medicare paid $426K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 2,389 | 1,801 | $5.67 | $14K |
| 99214 Office E&M - Established | Office | 1,355 | 1,121 | $76.51 | $104K |
| 93000 Electrocardiogram | Office | 1,058 | 951 | $9.09 | $9,622 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 632 | 158 | $6.55 | $4,138 |
| 93294 External Electrocardiographic Monitoring | Office | 508 | 146 | $18.78 | $9,541 |
| 93010 Electrocardiogram | Office | 471 | 463 | $6.07 | $2,858 |
| 93306 Echocardiography (TTE/TEE) | Office | 469 | 462 | $111.31 | $52K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 406 | 203 | $90.05 | $37K |
| 93306 Echocardiography (TTE/TEE) | Facility | 304 | 300 | $49.14 | $15K |
| 78452 Myocardial Perfusion Scan | Office | 271 | 271 | $241.22 | $65K |
| 93015 Electrocardiogram | Office | 236 | 235 | $46.37 | $11K |
| 99215 Office E&M - Established | Office | 192 | 176 | $120.11 | $23K |
| 93298 External Electrocardiographic Monitoring | Office | 190 | 23 | $18.36 | $3,489 |
| 99204 Office E&M - New | Office | 177 | 177 | $100.68 | $18K |
| 99232 Hospital E&M - Subsequent | Facility | 110 | 85 | $58.83 | $6,471 |
By year: 2022 $546K for 8,334 services; 2023 $544K for 10,562 services; 2024 $426K for 9,800 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gavin M Leask prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,043 prescriptions and refills. In total Gavin M Leask wrote 9,449 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 1,043 | 2,196 | 290 | $1.2M |
| Atorvastatin Calcium Generic | 987 | 2,842 | 306 | $11K |
| Metoprolol Succinate Generic | 683 | 1,877 | 229 | $11K |
| Metoprolol Tartrate Generic | 643 | 1,817 | 206 | $4,727 |
| Losartan Potassium Generic | 467 | 1,327 | 159 | $4,693 |
| Carvedilol Generic | 409 | 1,140 | 127 | $3,582 |
| Xarelto Rivaroxaban | 349 | 772 | 89 | $418K |
| Lisinopril Generic | 336 | 939 | 106 | $1,652 |
| Spironolactone Generic | 309 | 817 | 104 | $2,080 |
| Furosemide Generic | 298 | 768 | 116 | $1,406 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 289 | 731 | 87 | $4,327 |
| Rosuvastatin Calcium Generic | 270 | 787 | 100 | $3,720 |
| Ezetimibe Generic | 257 | 743 | 81 | $6,481 |
| Amlodipine Besylate Generic | 249 | 707 | 99 | $1,560 |
| Clopidogrel Clopidogrel Bisulfate | 200 | 546 | 66 | $1,742 |
Brand drugs: 1,856 claims; generic drugs: 7,593 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gavin M Leask $1,312 ($1,312 in general payments such as food, travel and fees) from 19 companies. The largest payer was Pfizer Inc. with $190.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 6 | $190 |
| Edwards Lifesciences Corporation EW | 1 | $175 |
| Merz North America, Inc. | 1 | $140 |
| Novo Nordisk Inc NVO | 5 | $112 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $108 |
| Amgen Inc. AMGN | 5 | $102 |
| Abbvie Inc. ABBV | 1 | $85.55 |
| Merck Sharp & Dohme LLC MRK | 5 | $79.94 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $66.61 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $43.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.